Relationship among sleep, work features, and SARS-cov-2 vaccine antibody response in hospital workers

Sleep Med. 2024 Apr:116:90-95. doi: 10.1016/j.sleep.2024.02.045. Epub 2024 Feb 29.

Abstract

Study objectives: Immunity is influenced by sleep and the circadian rhythm. Healthcare workers are predisposed to both insufficient sleep and circadian disruption. This study aimed to evaluate the relationship between sleep and work characteristics and the antibody response to the mRNA SARS-CoV-2 vaccine BNT162b2.

Methods: The authors' prospective cohort study ("COVI3") evaluated the effect of a third (booster) dose of the BNT162b2 vaccine. A subset of participants provided information on anthropometric measures, sleep, stress and work characteristics including shift work and number of work hours per week. Blood samples for anti-S1-RBD IgG antibody levels were obtained 21 weeks following receipt of the third dose of the vaccine.

Results: In total, 201 healthcare workers (73% women) were included. After adjustment for age, body mass index (BMI), shift work, smoking status, and perceived stress, short sleep duration (<7 h per night) was associated with lower anti-S1-RBD IgG levels (Odds ratio 2.36 [95% confidence interval 1.08-5.13]). Participants who performed shift work had higher odds of lower anti-S1-RBD IgG levels compared to those who did not work in shifts [odds ratio = 2.99 (95% confidence interval 1.40, 6.39)] after accounting for age, short sleep duration, BMI, smoking status and perceived stress.

Conclusions: Shift work and self-reported short sleep duration were associated with a lower antibody response following a booster dose of the SARS-CoV-2 vaccine. These findings suggest that the efficacy of vaccination, particularly among healthcare workers, may be augmented by addressing both sleep and circadian alignment.

Keywords: Antibody; Immunization; SARS-CoV-2; Shift work; Sleep curtailment; Vaccination.

MeSH terms

  • Antibody Formation
  • BNT162 Vaccine
  • COVID-19 Vaccines*
  • COVID-19* / prevention & control
  • Female
  • Hospitals
  • Humans
  • Immunoglobulin G
  • Male
  • Prospective Studies
  • SARS-CoV-2
  • Sleep

Substances

  • COVID-19 Vaccines
  • BNT162 Vaccine
  • Immunoglobulin G